双链聚肌胞
生物活性靶点体外研究体内研究 用途与合成方法 MSDS 双链聚肌胞价格(试剂级) 上下游产品信息
| 中文名称 | 双链聚肌胞 |
|---|---|
| 中文同义词 | 聚肌苷酸-聚胞苷酸钠盐;双链聚肌胞;6.双链聚肌胞(POLYI:C .);卡那霉素-聚肌胞钠盐复合物;双链聚肌胞钠盐;双链聚肌胞溶液;POLYI:C双链聚肌胞钠盐;聚肌苷 - 聚胞苷酸钠盐 |
| 英文名称 | Polyinosinic-polycytidylic acid sodium salt |
| 英文同义词 | POLYINOSINIC ACID + POLYCYTIDYLIC ACID, SODIUM SALT;Polymyocyte sodium salt;POLYINOSINIC ACID POLYCYTIDYLIC ACID, SODIUM SALT;POLYINOSINIC-POLYCYTIDYLIC ACID SODIUM SALT;POLY I POLY C, NA;POLY[I] POLY[C] SODIUM SALT;Oligochitosan-kanamycin-polyI-polyC sodium salt compound solution;Polyinosinic acid - polycytidylic acid sodium salt, double-stranded |
| CAS号 | 42424-50-0 |
| 分子式 | C19H27N7O16P2 |
| 分子量 | 671.41 |
| EINECS号 | 1308068-626-2 |
| 相关类别 | 医药中间体;中间体;兽用鉰料添加剂和婴幼儿奶粉添加;医药兽药;原料药;生化试剂-聚合物类;医药原料;化学试剂;Biochemicals and Reagents;Biomaterials;Cell Culture;Materials Science;Nucleosides;Nucleotides;Oligonucleotide Polymers and Copolymers;Oligonucleotides;Other adjuvants;Synthetic Oligonucleotides and Related Reagents;Vaccine Adjuvants;Vaccine Production |
| Mol文件 | 42424-50-0.mol |
| 结构式 | ![]() |
双链聚肌胞 性质
| 储存条件 | −20°C |
|---|---|
| 溶解度 | H2O:可溶,10mg/mL |
| 形态 | 冻干粉 |
| 颜色 | 白色至米白色 |
| 水溶解性 | Water : 10 mg/mL (Need ultrasonic and warming) |
双链聚肌胞 用途与合成方法
生物活性
Polyinosinic-polycytidylic acid sodium (Poly(I:C) sodium) 是双链 RNA 的合成类似物,是一种 TLR3 和视黄酸诱导型基因 I 受体 (RIG-I 和 MDA5) 的激动剂。Polyinosinic-polycytidylic acid sodium 可以用作疫苗佐剂,以增强先天性和适应性免疫反应,并改变肿瘤的微环境,还可以直接触发癌细胞发生凋亡。
靶点
TLR3, RIG-I, MDA5, apoptosis
体外研究
Polyinosinic-polycytidylic acid (20 ng/mL; 24 hours; WM793, WM278, WM239A, WM9 and 1205Lu cells) treatment strongly reduces viability from 100% in controls to 20%–50% within 24 hours.
Polyinosinic-polycytidylic acid (200 ng/mL; 24 hours; 1205Lu cells) treatment induces apoptosis in 1205Lu cells.
Polyinosinic-polycytidylic acid (3 ng/mL; 24 hours; 1205Lu cells) treatment induces IFN-β expression in melanoma cells. Silencing of RIG-I and MDA-5 confirmed that induction of IFN-β by Polyinosinic-polycytidylic acid required RIG-I and MDA-5, respectively, and that required IPS-1.
Polyinosinic-polycytidylic acid (5 ng/mL; 24 hours; 1205Lu cells) treatment reveals active subunits of caspase-9 and caspase-8 in melanoma cells.
Polyinosinic-polycytidylic acid sodium is prepared for injection by resuspending in sterile saline, heating to 50 °C at a concentration of 2 mg/ml to ensure complete solubilisation and then allowing to cool naturally to room temperature to ensure proper annealing of double-stranded RNA. Poly I:C is stored at -20 °C until use.
Cell Viability Assay
| Cell Line: | WM793, WM278, WM239A, WM9 and 1205Lu cells |
| Concentration: | 20 ng/mL |
| Incubation Time: | 24 hours |
| Result: | Strongly reduced viability from 100% in controls to 20%–50% within 24 hours. |
Apoptosis Analysis
| Cell Line: | 1205Lu cells |
| Concentration: | 200 ng/mL |
| Incubation Time: | 24 hours |
| Result: | Induced apoptosis in 1205Lu cells. |
RT-PCR
| Cell Line: | 1205Lu cells |
| Concentration: | 3 ng/mL |
| Incubation Time: | 24 hours |
| Result: | Induced IFN-β expression in melanoma cells. |
Western Blot Analysis
| Cell Line: | 1205Lu cells |
| Concentration: | 5 ng/mL |
| Incubation Time: | 24 hours |
| Result: | Revealed active subunits of caspase-9 and caspase-8 in melanoma cells. |
体内研究
Polyinosinic-polycytidylic acid treatment inhibits tumor growth in NOD/SCID immunodeficient mice injected with 1205Lu cells. The level of human DNA is 50% lower in mice treated with Polyinosinic-polycytidylic acid.
用途
一种可作为在TLR3水平对细胞信号转导进行研究的模型RNA的双链均聚物。也是一种TRIF依赖性toll样受体-3(TLR3)配体。
安全信息
| 安全说明 | 22-24/25 |
|---|---|
| WGK Germany | 3 |
| RTECS号 | TR0175000 |
MSDS信息
| 提供商 | 语言 |
|---|---|
SigmaAldrich | 英文 |
双链聚肌胞 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024/08/19 | HY-135748 | Polyinosinic-polycytidylic acid sodium | 5 mg | 1750元 | |
| 2024/08/19 | HY-135748 | 双链聚肌胞 Polyinosinic-polycytidylic acid sodium | 42424-50-0 | 10mg | 2800元 |



VIP会员
粤公网安备44196802000105号